key: cord-0713051-ifynep20
authors: Lemieux, Jacob E; Li, Jonathan Z
title: Uncovering Ways that Emerging SARS-CoV-2 Lineages May Increase Transmissibility
date: 2021-02-13
journal: J Infect Dis
DOI: 10.1093/infdis/jiab083
sha: b4762997af76522853a9107fd3da5eb660d81c59
doc_id: 713051
cord_uid: ifynep20

nan

A c c e p t e d M a n u s c r i p t

With the emergence of novel lineages that increase transmissibility and reduce the efficacy of vaccines, the SARS-CoV-2 pandemic is entering a new and dangerous phase. One of the first lineages of concern recognized was B.1.1.7 (also known as VOC-202012/01 and 501Y.V1), initially reported in the United Kingdom (UK) in September 2020. B.1.1.7 has risen quickly in prevalence across multiple independent regions 1 and appears to be approximately 50% more transmissible than most other SARS-CoV-2 genotypes 2-4 , a finding that has prompted intensified lockdown measures within the UK and travel restrictions in many countries. Preliminary evidence suggests that current vaccines and neutralizing antibodies remain effective against B.1.1. The emergence of B.1.1.7 and its associated mutations is reminiscent of the earlier studies of lineages that emerged in January 2020 and contain an aspartic acid to glycine substitution at position 614 of Spike (D614G) 13, 14 . Several studies showed that D614G may be associated with a higher nasopharyngeal SARS-CoV-2 viral load 13, 15, 16 , but the effect is much smaller (1) (2) (3) A c c e p t e d M a n u s c r i p t

on behalf of COVID-19 Genomics Consortium UK (CoG-UK). Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations. virological.org

Transmission of SARS-CoV-2 Lineage B. 1.1. 7 in England: Insights from linking epidemiological and genetic data. medRxiv

Estimated transmissibility and severity of novel SARS-CoV-2 Variant of Concern 202012/01 in England. medRxiv

Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom

Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera

SARS-CoV-2 501Y. V2 escapes neutralization by South African COVID-19 donor plasma. BioRxiv [Internet]. Cold Spring Harbor Laboratory Preprints

mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants. bioRxiv

SARS-CoV-2 reinfection by the new Variant of Concern (VOC) P. 1 in Amazonas, Brazil. SARS-CoV-2 reinfection by the new Variant of Concern (VOC) P

SARS-CoV-2 viral load predicts COVID-19 mortality

Massachusetts Consortium for Pathogen Readiness. SARS-CoV-2 viral load is associated with increased disease severity and mortality

Impact of SARS-CoV-2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients with Coronavirus Disease

Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding

Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus

Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant

High-Density Amplicon Sequencing Identifies Community Spread and Ongoing Evolution of SARS-CoV-2 in the Southern United States

A clade of SARS-CoV-2 viruses associated with lower viral loads in patient upper airways

A c c e p t e d M a n u s c r i p t